1. Home
  2. GTBP vs AIHS Comparison

GTBP vs AIHS Comparison

Compare GTBP & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • AIHS
  • Stock Information
  • Founded
  • GTBP 1965
  • AIHS 2014
  • Country
  • GTBP United States
  • AIHS China
  • Employees
  • GTBP N/A
  • AIHS N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • GTBP Health Care
  • AIHS Finance
  • Exchange
  • GTBP Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • GTBP 2.6M
  • AIHS 2.2M
  • IPO Year
  • GTBP N/A
  • AIHS 2018
  • Fundamental
  • Price
  • GTBP $0.65
  • AIHS $1.78
  • Analyst Decision
  • GTBP Strong Buy
  • AIHS
  • Analyst Count
  • GTBP 1
  • AIHS 0
  • Target Price
  • GTBP $11.00
  • AIHS N/A
  • AVG Volume (30 Days)
  • GTBP 4.5M
  • AIHS 1.2M
  • Earning Date
  • GTBP 11-13-2025
  • AIHS 11-13-2025
  • Dividend Yield
  • GTBP N/A
  • AIHS N/A
  • EPS Growth
  • GTBP N/A
  • AIHS N/A
  • EPS
  • GTBP N/A
  • AIHS N/A
  • Revenue
  • GTBP N/A
  • AIHS $3,370,162.00
  • Revenue This Year
  • GTBP N/A
  • AIHS N/A
  • Revenue Next Year
  • GTBP N/A
  • AIHS N/A
  • P/E Ratio
  • GTBP N/A
  • AIHS N/A
  • Revenue Growth
  • GTBP N/A
  • AIHS 8.56
  • 52 Week Low
  • GTBP $0.55
  • AIHS $1.63
  • 52 Week High
  • GTBP $4.10
  • AIHS $17.00
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 42.50
  • AIHS 40.97
  • Support Level
  • GTBP $0.65
  • AIHS $1.63
  • Resistance Level
  • GTBP $0.78
  • AIHS $2.01
  • Average True Range (ATR)
  • GTBP 0.06
  • AIHS 0.11
  • MACD
  • GTBP 0.01
  • AIHS -0.03
  • Stochastic Oscillator
  • GTBP 4.82
  • AIHS 25.42

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

Share on Social Networks: